Provide feedback
Search
Subscribe
Login
I need to set up an account
Rheumatology
Rheumatology
Conferences
Arthritis
More Specialties
Cardiology
Cardiac Surgery
Dermatology
Endocrinology
Gastroenterology
General Surgery
Infectious Disease
Internal Medicine
Nephrology
Neurology
Neurosurgery
Hematology/Oncology
Ophthalmology
Orthopedics
Orthopaedics
Pediatrics
Psychiatry
Primary Care
Pulmonary/Respiratory
Rheumatology
Urology
Women's Health
FDA News
Managed Care
Boxed warning added to Plavix label regarding possible reduced efficacy in certain patients
FDA approves five-day dosing regimen of Eisai's Dacogen for MDS
FDA approves Watson's six-month Trelstar formulation for palliative treatment of advanced prostate cancer
Abbott submits sNDA for new formulation of Lupron Depot in advanced prostate cancer
FDA grants 510(k) clearance to Fenwal to market Amicus blood cell separator for platelet-related use
Private FFS MA plans may be linked with higher costs for beneficiaries, GAO report shows
Pediatric subspecialty telephone consultations may be cost-saving for Medicaid, research reveals
Use of mental health services greater in health plans with parity in cost sharing, data find
Public opinions appear split on health care affordability, satisfaction, survey finds
In Brief: California Supreme Court
Home
::
Rheumatology
:: Rheumatology Conferences
ACR 2007 Scientific Meeting
November 6-11, 2007 Boston, MA
Etanercept provides sustained efficacy, improved patient-reported outcomes in AS
Targeting the IL-6 cytokine pathway presents exciting opportunities in variety of disease states, experts report
Rituximab efficacious in patients with inadequate response to TNF inhibitors in repeated courses
Treatment expectations with TNF inhibitors
Adalimumab improves peripheral arthritis, enthesitis, axial signs, symptoms of AS in patients with long-standing disease treated in real-life practice, researchers report
More
EULAR 2007 Annual Congress
June 13-16, 2007 Barcelona, Spain
Biologics represent useful treatment for PsA; other therapies, approaches require more study
Repair of joint erosions in patients with RA occurs primarily in joints with no swelling, improvement in swelling, researchers report
Adalimumab safe, effective in anti-TNF-pretreated patients with PsA, study data show
Certolizumab pegol improves signs, symptoms of RA among patients with insufficient response to methotrexate, study data show
Anti-TNF agents may slow, protect against RA-related joint destruction, disability, work loss
More
Most Read
Most Emailed
Adalimumab improves peripheral arthritis, enthesitis, axial signs, symptoms of AS in patients with long-standing disease treated in real-life practice, researchers report
Infliximab infusion may increase risk of ventricular arrhythmias in patients with RA, data suggest
Adalimumab improves symptoms, patient-reported outcomes in patients with psoriasis, PsA, data show
Oral JAK-3 inhibitor plus methotrexate efficacious, safe in RA
Golimumab improves signs, symptoms, physical function among patients with AS, study data show
Infliximab infusion may increase risk of ventricular arrhythmias in patients with RA, data suggest
Canadian Rheumatology Association, Spondyloarthritis Research Consortium of Canada publish recommendations for treatment of SpA
Denosumab, certolizumab show promise as potential treatments in RA
Oral JAK-3 inhibitor plus methotrexate efficacious, safe in RA
Increase in risk of heart failure slight among younger anti-TNF-treated patients with RA, Crohn's disease